biotech picks

Updated:
08.13.07
Views:
User Rating:
4.00/1
TheStreet Rating:
D+
RATE NOW
Log in to rate this portfolio
Follow
Log in to follow

Description:

speculative biotech microcaps owned; others to add but still accumulating.
7/15: bought more PPHM last week .76-.79; pvt placement @.75 caused drop, but new ph 2 study planned on combined bavitaximub with paclitaxel and carboplatin in lung ca (non small cell );
8/1 added 3 others to this list that I had been accumulating.
Biotechs in downtrend like market at present, hopefully these selections will perform on their science and be rewarded in the marketplace when the market is recovering.
8/11: recent blogs: ACUS on Zacks.com; CPHI on seeking alpha
8/13: REX on yahoo message boards: research report offered by Diggs Deep
(caveat=he was paid to write research report) which was very in depth and positive. Good explanation of immunology behind ovarex cellular immunity;

Add Comment

Add Comment

Most Viewed Portfolios

View All

Articles

6 Winning Stocks for Awards Season

02.13.12 | 06:37 PM

MILLBURN, N.J. (Stockpickr) -- We are in the heart of awards season. The Golden Globes Awards ceremony was held on Jan. 15, and the first-ever NFL ...